Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Osteonecrosis
and you are
between 8 and 40
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The goal of the project is to evaluate osteonecrosis before and after decompression surgery with ferumoxytol-enhanced MRI.

Provided treatments

  • Drug: Ferumoxytol-enhanced magnetic resonance imaging
  • Device: Magentic Resonance Imaging
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02893293. The sponsor of the trial is Stanford University and it is looking for 20 volunteers for the current phase.
Official trial title:
Imaging of Osteonecrosis With Ferumoxytol-Enhanced MRI